Neonatal Seizures Clinical Trial
Official title:
NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent
NEMO is a multicentre pan European clinical trial with the aim to develop new treatment strategies for the treatment of neonatal seizures using the loop diuretic bumetanide. There is evidence that bumetanide improves GABAergic function of the current standard drug, phenobarbitone. Bumetanide has been used as a diuretic in term and preterm babies for around thirty years. This trial should confirm that Bumetanide in addition to standard treatment will result in better seizures control.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01089504 -
Prophylactic Phenobarbital After Neonatal Seizures
|
Phase 4 | |
Terminated |
NCT02550028 -
Levetiracetam Treatment of Neonatal Seizures
|
Phase 1/Phase 2 | |
Completed |
NCT02789176 -
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
|
||
Not yet recruiting |
NCT02602015 -
Levetiracetam Treatment of Neonatal Seizures
|
Phase 1/Phase 2 | |
Terminated |
NCT01475656 -
Efficacy of Keppra for Neonatal Seizures
|
N/A | |
Recruiting |
NCT03107507 -
Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG
|
Phase 4 | |
Completed |
NCT01720667 -
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
|
Phase 1/Phase 2 | |
Recruiting |
NCT05079971 -
EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy
|
N/A | |
Completed |
NCT02229123 -
Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study
|
Phase 2 | |
Completed |
NCT02160171 -
ANSeR- The Algorithm for Neonatal Seizure Recognition Study
|
N/A |